DE3750571T2 - Herstellung von rekombinantem, menschlichem PSTI. - Google Patents

Herstellung von rekombinantem, menschlichem PSTI.

Info

Publication number
DE3750571T2
DE3750571T2 DE3750571T DE3750571T DE3750571T2 DE 3750571 T2 DE3750571 T2 DE 3750571T2 DE 3750571 T DE3750571 T DE 3750571T DE 3750571 T DE3750571 T DE 3750571T DE 3750571 T2 DE3750571 T2 DE 3750571T2
Authority
DE
Germany
Prior art keywords
production
psti
human psti
recombinant human
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750571T
Other languages
English (en)
Other versions
DE3750571D1 (de
Inventor
Michio Ogawa
Kenichi Matsubara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE3750571D1 publication Critical patent/DE3750571D1/de
Application granted granted Critical
Publication of DE3750571T2 publication Critical patent/DE3750571T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/06—Methods or installations for obtaining or collecting drinking water or tap water from underground
    • E03B3/08—Obtaining and confining water by means of wells
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/40—Other devices for confining, e.g. trenches, drainage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Hydrology & Water Resources (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE3750571T 1986-10-14 1987-10-14 Herstellung von rekombinantem, menschlichem PSTI. Expired - Fee Related DE3750571T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61245049A JPH0616716B2 (ja) 1986-10-14 1986-10-14 酵母におけるヒトｐｓｔｉの製造法

Publications (2)

Publication Number Publication Date
DE3750571D1 DE3750571D1 (de) 1994-10-27
DE3750571T2 true DE3750571T2 (de) 1995-03-30

Family

ID=17127817

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750571T Expired - Fee Related DE3750571T2 (de) 1986-10-14 1987-10-14 Herstellung von rekombinantem, menschlichem PSTI.

Country Status (8)

Country Link
EP (1) EP0267692B1 (de)
JP (1) JPH0616716B2 (de)
KR (1) KR950010817B1 (de)
AT (1) ATE111955T1 (de)
AU (1) AU597115B2 (de)
CA (1) CA1340393C (de)
DE (1) DE3750571T2 (de)
ES (1) ES2064319T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339736C (en) * 1986-10-14 1998-03-17 Shionogi & Co., Ltd. Method for preparing fusion proteins
AU8172787A (en) * 1986-10-30 1988-05-25 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
JPS6427473A (en) * 1987-07-23 1989-01-30 Mochida Pharm Co Ltd Human pancreas-secreting trypsin inhibitor and production thereof
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DE3907492A1 (de) * 1989-03-08 1990-09-13 Biotechnolog Forschung Gmbh Verfahren zur isolierung und reinigung von hpsti und hpsti-varianten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
EP0561137B1 (de) * 1983-04-25 2002-07-03 Chiron Corporation Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
CA1339736C (en) * 1986-10-14 1998-03-17 Shionogi & Co., Ltd. Method for preparing fusion proteins
AU8172787A (en) * 1986-10-30 1988-05-25 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same

Also Published As

Publication number Publication date
ES2064319T3 (es) 1995-02-01
AU597115B2 (en) 1990-05-24
JPH0616716B2 (ja) 1994-03-09
KR950010817B1 (ko) 1995-09-23
EP0267692A3 (en) 1989-10-25
AU7976487A (en) 1988-04-28
EP0267692B1 (de) 1994-09-21
KR880005264A (ko) 1988-06-28
JPS6398397A (ja) 1988-04-28
EP0267692A2 (de) 1988-05-18
DE3750571D1 (de) 1994-10-27
ATE111955T1 (de) 1994-10-15
CA1340393C (en) 1999-02-16

Similar Documents

Publication Publication Date Title
LU91304I2 (fr) A tryn-antithrombin alfa
NZ222450A (en) Synthetic dna, peptide synthesis and regulation of transcription of silk like protein
ATE78294T1 (de) Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
DE69013811T2 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
DE3855449D1 (de) DNS-Klone von menschlichem Thrombomodulin
ATE124454T1 (de) Gentechnische herstellung von faktor xiiia.
DE3853446T2 (de) Fibronectinbindungsprotein und dessen Herstellung.
DE3750571D1 (de) Herstellung von rekombinantem, menschlichem PSTI.
ATE123303T1 (de) D-aminosäureoxidase.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
ATE95242T1 (de) Hefe-expressionssystem.
DE59409964D1 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
DE3855665D1 (de) Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
DE69116704T2 (de) Gen, das ein Polypeptid mit Nitrilhydratase-Aktivität codiert, eine dieses Gen enthaltende Transformante und Verfahren zur Herstellung von Amiden mit dieser Transformante.
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
DE3750240T2 (de) Gen, das ein Insektizid-Protein kodiert, und Herstellung des Proteins durch Verwendung dieses Gens.
ATE60801T1 (de) Expressionsvektoren fuer alpha-amylase in bacillus subtilis, erhaltene staemme und verfahren zur herstellung von alpha-amylase.
DE3767629D1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee